ID

36881

Beschreibung

Focal Prostate Radio-Frequency Ablation; ODM derived from: https://clinicaltrials.gov/show/NCT02328807

Link

https://clinicaltrials.gov/show/NCT02328807

Stichworte

Versionen (1)
  1. 18.06.19 18.06.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

18. Juni 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT02328807

Englisch

Eligibility Prostate Cancer NCT02328807

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
men 18 years of age or older
Beschreibung

Gender | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
diagnosis of adenocarcinoma of the prostate, confirmed by h.l. moffitt cancer center review
Beschreibung

Adenocarcinoma of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0007112
no prior treatment for prostate cancer
Beschreibung

Prostate carcinoma Untreated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0332155
eastern cooperative oncology group (ecog) performance status of 0 or1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
prostate cancer clinical stage t2a and below
Beschreibung

Prostate carcinoma TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C3258246
psa <10 ng/ml (this will be the prostatic specific antigen (psa) level prompting the initial prostate biopsy)
Beschreibung

Prostate specific antigen measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201544
prostate size <60 cc on transrectal ultrasound
Beschreibung

Size of prostate TRUS

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1287816
UMLS CUI [1,2]
C0373345
pre-enrollment biopsy parameters (as per h.l. moffitt c.c. review): minimum of 10 biopsy cores; no primary pattern biopsy gleason grade 4 or 5; unilateral cancer (only right-sided or left-sided, not bilateral); no more than 1 core with 50% cancer; no more than 4 cores with positive biopsies with gleason pattern 3 + 3 and no more than 2 cores with positive biopsies containing gleason pattern 3 + 4.
Beschreibung

Biopsy Parameters | Status pre- Enrollment | Core biopsy Quantity Minimum | Primary Gleason pattern | Neoplasm Unilateral | Neoplasm Percentage Core biopsy | Core biopsy Positive Quantity Gleason pattern

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C0449381
UMLS CUI [2,1]
C0332152
UMLS CUI [2,2]
C1516879
UMLS CUI [3,1]
C1318309
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C1524031
UMLS CUI [4]
C1273604
UMLS CUI [5,1]
C0027651
UMLS CUI [5,2]
C0205092
UMLS CUI [6,1]
C0027651
UMLS CUI [6,2]
C0439165
UMLS CUI [6,3]
C1318309
UMLS CUI [7,1]
C1318309
UMLS CUI [7,2]
C1514241
UMLS CUI [7,3]
C1265611
UMLS CUI [7,4]
C1273606
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
men less than 18 years of age
Beschreibung

Gender | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
medically unfit for anesthesia
Beschreibung

Medically unfit Anesthesia

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3841806
UMLS CUI [1,2]
C0002903
histology other than adenocarcinoma
Beschreibung

Histology | Exception Adenocarcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0344441
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0001418
biopsy does not meet inclusion criteria
Beschreibung

Biopsy Inclusion criteria failed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C1512693
UMLS CUI [1,3]
C0231175
men who have received any hormonal manipulation (antiandrogens; luteinizing hormone releasing hormone (lhrh) agonist; 5-alpha-reductase inhibitors) within the previous 6 months
Beschreibung

Gender Hormone manipulation | Androgen Antagonists | LHRH Agonist | 5-alpha Reductase Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0586971
UMLS CUI [2]
C0002842
UMLS CUI [3]
C1518041
UMLS CUI [4]
C2936788
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Prostate Cancer NCT02328807

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
men 18 years of age or older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Adenocarcinoma of prostate
Item
diagnosis of adenocarcinoma of the prostate, confirmed by h.l. moffitt cancer center review
boolean
C0007112 (UMLS CUI [1])
Prostate carcinoma Untreated
Item
no prior treatment for prostate cancer
boolean
C0600139 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or1
boolean
C1520224 (UMLS CUI [1])
Prostate carcinoma TNM clinical staging
Item
prostate cancer clinical stage t2a and below
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Prostate specific antigen measurement
Item
psa <10 ng/ml (this will be the prostatic specific antigen (psa) level prompting the initial prostate biopsy)
boolean
C0201544 (UMLS CUI [1])
Size of prostate TRUS
Item
prostate size <60 cc on transrectal ultrasound
boolean
C1287816 (UMLS CUI [1,1])
C0373345 (UMLS CUI [1,2])
Biopsy Parameters | Status pre- Enrollment | Core biopsy Quantity Minimum | Primary Gleason pattern | Neoplasm Unilateral | Neoplasm Percentage Core biopsy | Core biopsy Positive Quantity Gleason pattern
Item
pre-enrollment biopsy parameters (as per h.l. moffitt c.c. review): minimum of 10 biopsy cores; no primary pattern biopsy gleason grade 4 or 5; unilateral cancer (only right-sided or left-sided, not bilateral); no more than 1 core with 50% cancer; no more than 4 cores with positive biopsies with gleason pattern 3 + 3 and no more than 2 cores with positive biopsies containing gleason pattern 3 + 4.
boolean
C0005558 (UMLS CUI [1,1])
C0449381 (UMLS CUI [1,2])
C0332152 (UMLS CUI [2,1])
C1516879 (UMLS CUI [2,2])
C1318309 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C1524031 (UMLS CUI [3,3])
C1273604 (UMLS CUI [4])
C0027651 (UMLS CUI [5,1])
C0205092 (UMLS CUI [5,2])
C0027651 (UMLS CUI [6,1])
C0439165 (UMLS CUI [6,2])
C1318309 (UMLS CUI [6,3])
C1318309 (UMLS CUI [7,1])
C1514241 (UMLS CUI [7,2])
C1265611 (UMLS CUI [7,3])
C1273606 (UMLS CUI [7,4])
Item Group
C0680251 (UMLS CUI)
Gender | Age
Item
men less than 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Medically unfit Anesthesia
Item
medically unfit for anesthesia
boolean
C3841806 (UMLS CUI [1,1])
C0002903 (UMLS CUI [1,2])
Histology | Exception Adenocarcinoma
Item
histology other than adenocarcinoma
boolean
C0344441 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0001418 (UMLS CUI [2,2])
Biopsy Inclusion criteria failed
Item
biopsy does not meet inclusion criteria
boolean
C0005558 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
Gender Hormone manipulation | Androgen Antagonists | LHRH Agonist | 5-alpha Reductase Inhibitors
Item
men who have received any hormonal manipulation (antiandrogens; luteinizing hormone releasing hormone (lhrh) agonist; 5-alpha-reductase inhibitors) within the previous 6 months
boolean
C0079399 (UMLS CUI [1,1])
C0586971 (UMLS CUI [1,2])
C0002842 (UMLS CUI [2])
C1518041 (UMLS CUI [3])
C2936788 (UMLS CUI [4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video